Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) aim to re-establish cancer immune control by modulating immune-inhibitory signaling pathways. ICIs are currently approved in breast cancer treatment act by blocking cell anti-PD-1/PD-L1 interactions. Nonetheless, as many mechanisms of immune escape...

Descripción completa

Detalles Bibliográficos
Autores principales: Massa, Davide, Tosi, Anna, Rosato, Antonio, Guarneri, Valentina, Dieci, Maria Vittoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562913/
https://www.ncbi.nlm.nih.gov/pubmed/36230808
http://dx.doi.org/10.3390/cancers14194885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562913/
https://www.ncbi.nlm.nih.gov/pubmed/36230808
http://dx.doi.org/10.3390/cancers14194885

Ejemplares similares